T- cell depleted peripheral blood stem cell (TCD-PBSC) transplants secure consistent engraftment with low risk of acute or chronic GVHD and favorable disease free survival (DFS) and overall survival (OS) for pediatric patients (< 21 years) with AML in CR1

Autor:	Kernan, N. A., Boulad, F., Prockop, S. E., Scaradavou, A., Kobos, R., Lehrman, R., Elizabeth Klein, Wolden, S., Curran, K. J., Hasan, A. N., Bleau, S., Ruggiero, J. M., Zakak, N., Casson, A., Torok-Castanza, J., O Reilly, R. J.
Zdroj:	Memorial Sloan Kettering Cancer Center
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::04e494e88ed219156e248de68deb8e7a https://synapse.mskcc.org/synapse/works/91702 Zobrazit plný text záznamu